Phlo Corporation (OTCBB:PHLC - news; "Phlo") announced today the execution of an agreement providing for the exclusive license, for all uses, worldwide, of a proprietary (patent-pending) composition which in tests has demonstrated the capability of eliminating acne with consistent use within a period of three weeks to three months, depending on the severity of the condition.